Vascular Disease and Insulin Resistance

- July 20, 2008

Welcome to the #1 online source of information for Diabetes Specialists! An international online community of more than 10,000 Diabetes Specialists.

CME on Diabetes is a website built to transmit top-level CME conferences given by international experts in endocrinology, insulin resistance, prediabetes, metabolic syndrome and type 2 diabetes. More than 2.6 million slides have been viewed since the website launch. Thank you for your continued support and commitment!

Presentation

"Vascular Disease and Insulin Resistance"

Prof. Giancarlo Viberti (biography)
English - 2005-05-06 - 51 minutes

(60 slides)

(6 questions)

Summary :
Insulin resistance increases the risk of cardiovascular disease, and Prof. Viberti describes data showing the relationships between traditional and non-traditional CVD risk factors and insulin resistance, as well as their associated risks.

PPAR gamma agonists affect the metabolic pathways of insulin signaling by improving insulin sensitivity, and also the trophic pathways mainly through the MAPK signaling molecules. Prof. Viberti reviews several studies showing the effects of rosiglitazone treatment on various factors impacting on vascular risk.

Copyright © 2005 E-MedHosting.com Inc.

Learning objectives :
After viewing this presentation the participant will be able to discuss:

- CVD risk factors and insulin resistance
- The effects of PPAR gamma agonists

Login

	Username :
	Password :

	Lost your password?

Search our website

	Would you like to know more about insulin resistance? Are you looking for information pertaining to Type 2 Diabetes? You can find what you are looking for in over 2000 references available on CMEonDiabetes.

Social

Let others know about this presentation.

	Del.icio.us
	Digg!

ezCME: HIV - Insulin Resistance - C-Reactive Protein (CRP) - ADHD - Sleep Disorder - Prostate Health - Hemophilia - Transplantation

Copyright © 2002-2008 E-MedHosting.com. All rights reserved. Disclaimer
USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.